{
  "docId": "019de073-b144-743c-94c4-bc5a80eb44df",
  "docSlug": "9540d42c57dd536e8cb82c97bd211004",
  "documentTitle": "Dare Bioscience | Investor Presentation Deck | 50 slides",
  "authorId": "dare-bioscience",
  "authorName": "Daré Bioscience",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 17,
  "pageCount": 50,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide uses a three-row layout to contrast the problem, current limitations, and the proposed solution.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-b144-743c-94c4-bc5a80eb44df/17",
  "deckHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df",
  "deckJsonHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df.json",
  "deckAnchorHref": "/decks/019de073-b144-743c-94c4-bc5a80eb44df#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.11,
        "y": 0.87
      },
      "kind": "callout",
      "text": "Daré Innovation: XACIATO™ (Clindamycin Phosphate) Vaginal Gel, 2%*",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e39f433b-1b8e-46c5-bf40-a915b72e21e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.72,
        "x": 0.26,
        "y": 0.11
      },
      "kind": "list",
      "text": "Recurring infection, difficult to treat effectively; Most common vaginal condition in women ages 15-44; Affects ~21 million women in the US; Bacterial Vaginosis increases health risks, including increased risk of preterm birth, STIs, etc.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2764f85c-f0ed-4d14-8141-e44a5dd33269",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.72,
        "x": 0.26,
        "y": 0.37
      },
      "kind": "list",
      "text": "Bacterial vaginosis is a disruption in the optimal vaginal microbiome and therefore recurrent in many women; Women experiencing recurrence have three or more episodes in the same year; Current Rx suboptimal: clinical cure rates of 37-68%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a078081-1734-4050-b1bd-27bacb373526",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.72,
        "x": 0.26,
        "y": 0.62
      },
      "kind": "list",
      "text": "Single self-administered dose, any time of day; Vaginal delivery of the antibiotic, with minimal systemic exposure; Colorless, odorless gel; Demonstrated equivalent cure rates; Clear labeling for special populations",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db03422f-50f4-4335-b430-8a330641c610",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.14,
        "x": 0.07,
        "y": 0.69
      },
      "kind": "paragraph",
      "text": "Target Product Profile",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15867cf3-5ef7-4e8a-a861-cefabc0496c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.18,
        "x": 0.05,
        "y": 0.42
      },
      "kind": "paragraph",
      "text": "Limitations with current standards of care",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b5cdc5e-ac4c-4d0d-9f1f-acc85a86f76f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.12,
        "x": 0.08,
        "y": 0.225
      },
      "kind": "paragraph",
      "text": "Clinical Issue",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be0bcfe7-abc4-46e5-bed4-2ecb7355f230",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.03,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. CDC stats; 2. Mayo Clinic; 3. Product data",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9ba2a4b7-cf05-4a08-890d-ef4fbb390465",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.24,
        "x": 0.38,
        "y": 0.03
      },
      "kind": "title",
      "text": "Bacterial Vaginosis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a5c6e0bf-0bdf-4271-b914-b329df958ac2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "750b4041-2dee-4786-8bc8-2b9252a99a23",
      "evidence": "Contrasts current clinical issues/limitations with the target product profile solution.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 17,
      "from": 17,
      "beatId": "d8ea863d-05b8-4eba-95ab-e902bb646952",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The problem statement on page 17 aligns with the Sequoia Pitch Problem beat.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 17,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "e9054d9b-fe14-4a0d-ab5b-ea433a23ce55",
      "evidence": "The problem statement and context on pages 17-18 suggest a cost of inaction loop.",
      "position": 1,
      "objective": "What is the cost of not addressing women's health?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}